COH 606 Health adn Medical Question – Description
Question 4 (5 points)
Populate a new 2×2 table with the information as follows. A new test to evaluate Campylobacteriosis was developed by Gilead Pharmaceuticals. A total of 100 people were tested for the disease. Of the 100 people total test 25 people were positive. When the 25 specimens were cultured it was found that 15 of the 25 were truly positive. The negative tests were cultured and evaluated as well. 25 of the tests that came up negative were positive. Calculate the sensitivity and specificity.You have just finished administering a food/drink questionnaire to ill and non-ill participants in a Minnesota summer picnic party. The ill individuals developed moderate to severe diarrhea 16 to 46 hours after the picnic. Six persons experienced vomiting. The following data were collected:
Question 5 (5 points)
You are interested in controlling cigarette smoking among women aged 15-24. Describe one primary prevention approach and one secondary prevention approach you would use. Convey your understanding of the difference between primary and secondary approaches in the context of your answer.
Question 1
Calculate the Odds ratio for illness for consuming Hot Dogs.
Question 2 (5 points)
You have just finished administering a food/drink questionnaire to ill and non-ill participants in a Minnesota summer picnic party. The ill individuals developed moderate to severe diarrhea 16 to 46 hours after the picnic. Six persons experienced vomiting. The following data were collected:
Calculate the Odds ratio for illness for consuming Hamburgers. Interpret the results.
Question 3 (5 points)
Different measures of disease are useful to evaluate and assess public health programs and needs in different situations. For each of the following questions, (a) state which measure would best support your goal and (b) explain why you chose that measure. To demonstrate the amount of children’s exposure to secondhand cigarette smoke.
The post COH 606 Health adn Medical Question first appeared on .
